Seema Naik

13PUBLICATIONS
76CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 12, 2026
A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B-Cell Lymphoma.

|Jun 12, 2026
Molecular Insights and Novel Therapies for Lymphoproliferative Disorders.

|Apr 21, 2026
Mosunetuzumab plus polatuzumab vedotin in relapsed/refractory MCL after BTK inhibitor therapy: a phase 2 study.

|Mar 27, 2026
Analyzing Real-World Infection Risk in Multiple Myeloma Patients Receiving Teclistamab.

Paddy Ssentongo, Emma G Guare, Chen Song

|Aug 27, 2024
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.

Narendranath Epperla, Adam S Zayac, Daniel J Landsburg

|Apr 13, 2024
IMPROVE-BMT: A Pilot Randomized Controlled Trial of Prehabilitation Exercise for Adult Hematopoietic Stem Cell Transplant Recipients.

Melanie Potiaumpai, Maxime Caru, Shin Mineishi

Pageof 3

Frequent Collaborators

4 joint publications

Narendranath Epperla

3 joint publications

Adam Zayac

3 joint publications

Bradley M Haverkos

3 joint publications

David A Bond